StockTipsArenaBeta

BUY Alkem Laboratories Limited — Nuvama Wealth

BUYAlkem Laboratories Limited

byNuvama WealthHorizon: NA (inferred 1 year)17 Aug 2026via ET Now (Live)

Entry₹5,379.5Inferred
Target₹6,130
Total upside +13.95%
Stop lossNot given
CMP₹5,1902d ago
Active-3.52%+18.11%upside left 12 mo left
Follow Nuvama Wealth for new calls(65% target hit, 153 closed calls)Get alertsWatch ALKEM for new buy/sell callsGet alertsSee 7 other Long-term calls on ALKEMSee 251 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 6 Sept, 4:43 pm IST
15 supporting6 neutral3 opposing
Supports the BUY call (15)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·4 Sept · 2d ago

Elara initiates coverage on Alkem, Eris, IPCA and Mankind. Check ratings and targets

NewsEt-Markets·28 Aug · 1w ago

(opens in new tab)

2 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·28 Aug · 1w ago

Alkem Labs Q1 Results: Shares down 3% after profit falls; revenue rises 11%

NewsCnbc-Tv18·14 Aug · 3w ago

(opens in new tab)

Four midcap stocks near 52-week highs that still look cheap

NewsLivemint·11 Aug · 4w ago

(opens in new tab)
Neutral / worth noting (6)

Broker’s Call: Alkem Laboratories (Buy)

NewsHbl·1 Sept · 5d ago

(opens in new tab)

Buy, Sell Or Hold: Ola Electric, Gillette India, Vedanta, Paytm, Ashok Leyland, Alkem Laboratories — Ask Profit

NewsNdtv-Profit·21 Aug · 2w ago

(opens in new tab)

Five reasons behind Investec's upgrade of Alkem Labs, and why JPMorgan is cautious

NewsCnbc-Tv18·17 Aug · 3w ago

(opens in new tab)

Alkem Laboratories Limited announced the outcome of its Board Meeting held on August 14, 2026. The board approved the standalone and consolidated unaudited financial results for the quarter ended June

NSE · Outcome of Board Meeting·14 Aug · 3w ago

(opens in new tab)
Weighs against the BUY call (3)

2 other SEBI-registered advisors have active long-term SELL calls on this stock

Advisor consensus · same horizon·17 Aug · 3w ago

Alkem Laboratories Q1 Result: Net Profit Drops 22% Despite Revenue Growth

NewsNdtv-Profit·14 Aug · 3w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.